Global Stem Cell Therapy Market to Witness Rapid Growth as Focus on Human Embryonic Stem Cells Grows

Published Date : Aug 22, 2016

ALBANY, NY, Aug 22, 2016: has recently announced the inclusion of a new market intelligence study to its vast repository of research reports. The 248-page research study, titled “PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy,” offers a detailed reports of the market, throwing light on the key opportunities and trends in the overall market. The key growth drivers, challenges, product segmentation, vendor reports, and key geographical segments of the global market for stem cell therapy have been discussed in the scope of the research report. 

Furthermore, the research study has taken help of numerous tools to determine the key growth drivers for the market and has presented the historical data and forecast figures of the market. The expected growth rate of the overall market has also been given in the research study in order to guide the decision-makers in designing effective business policies throughout the forecast period. 

Stem cell therapy is gaining immense popularity across the globe, due to which the overall market is estimated to witness significant growth in the next few years. The emergence of advanced genomic procedures for stem cell reports, the rising focus on human embryonic stem cells, and the rising funding for new stem cell lines are some of the key factors estimated to augment the growth of the market in the next few years. In addition, the emergence of new and innovative stem cell therapies and developing markets that are expected to unfold new horizons, owing to the low regulatory hurdles, is anticipated to create several opportunities for the key players in the coming few years.

For Sample Copy, click here:

On the flip side, the absence of necessary infrastructure and the ethical issues concerning the use of embryonic stem cells are estimated to impede the growth of the stem cell therapy market across the globe in the coming few years. However, collaborations between leading pharmaceutical companies and the rising focus of key players on emerging markets are expected to generate potential opportunities throughout the forecast period.

The research study has classified the global market for stem cell therapy on the basis of cell type into fetal, amniotic, induced pluripotent, embryonic, cord blood-derived, and adult stem cells. The size of each segment and its expected growth rate in the coming years have been included in the research study in order to give a clear understanding of the market.

The research study throws light on the key players engaged in the stem cell therapy market across the globe and provides an in-depth reports of the same. The prominent players operating in the market are Hygieia Innovation, Pharmicell, K-Stemcell, Neuralstem, Cellerant Therapeutics, Mesoblast, Stemedica, Tulane University, Bone Therapeutics, Celgene, Anterogen, NeoStem, StemCells, and Pluristem. The prime strategies adopted by the leading players in the market have also been highlighted in the study to guide the entrants in formulating their policies effectively in the next few years.

To order report Call Toll Free: 866-997-4948 or send an email on